Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-705-7 | CAS number: 1228186-15-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
The acute oral toxicity of the substance was assessed using:
-2 acute oral toxicity limit tests performed in rats according to OECD 423 and 401 guidelines and Good Laboratory Practices (Longobardi, 2002a and Daamen, 1991a).
The substance is of low acute toxicity following oral exposure:
The oral LD0 was found to be greater than 2000 mg/kg bw in both sexes.
The acute dermal toxicity of the substance was assessed using:
- An acute dermal toxicity test performed in rats according to OECD 402 guideline and Good Laboratory Practices (Queudot, 2010).
The substance is of low acute toxicity following dermal exposure:
The oral LD0 was found to be greater than 2000 mg/kg bw.
No information regarding the acute inhalation toxicity of the substance were available.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute Oral Toxicity:
Two reliable without restrictions studies were reported for the acute oral toxicity endpoint. The Longobardi (2002a) and the Daamen (1991) studies reached the same conclusions about the toxicity of the substance and were therefore identified as key studies.
The study of Longobardi (2002a) was designed to evaluate the toxicity of the test material following a single oral administration in rats according to the OECD guideline 423 and to the EU Method B.1 tris. The study was conducted in compliance with the principles of Good Laboratory Practice regulations.
As the oral toxicity was expected to be low, a limit test at one dose level of 2000 mg/kg bw was carried out with 6 animals,3 males in the first step and 3 females in the second step.The test material was prepared in aqueous solution containing 0.5%(w/v) carboxymethylcellulose and was administered by gavage under a dosage-volume of 10 ml/kg.
Clinical signs, mortality and body weight were checked for a period of 14 days following the single administration of the test item. All animals were subjected to necropsy.
No mortalities occurred in both the male and females. In males, clinical signs were limited to hunched posture and reduced activity but a full recovery was noted by Day 7. In females, no clinical signs were noted up to Day 7 of the observation period but therafter, difficulty in breathing, cold to touch, hunched posture, piloerection and rales were noted in a single animal. Changes in bodyweight observed in treated animals were in general not remarkable and no abnormalities were observed at necropsy.
Under these experimental conditions, the oral LD0 of the test material was equal or higher than 2000 mg/kg bw in rats.
The purpose of the study of Daamen (1991a) was to assess the toxicity of the test material when administered to rats as a single oral dose. The study was carried out in accordance with OECD Guideline No. 401, 'Acute Oral Toxicity and EEC Directlve 84/449/EEC, Part 8.1, "Acute Toxicity-Oral". The test material was administered by oral gavage, to five rats of each sex, at 2000 mg / kg bw.
Clinical signs, mortality and body weight were checked for a period of 14 days following the single administration of the test item. All animals were subjected to necropsy.
At the dose-level of 2000 mg/kg, no mortality, no clinical signs and no effects on body weight gain were observed. There were no apparent abnormalities at necropsy.
Under these experimental conditions, the oral LD0 of the test material was equal or higher than 2000 mg/kg bw in rats.
Acute dermal Toxicity:
One study is recorded for this endpoint.The study of Queudot (2010) was reliable without restrictions and selected as a key study.
The study of Queudot (2010) was conducted to evaluate the potential acute dermal toxicity of the substance in rats.
The study was conducted according to OECD guideline 402 and EU method B.3 in compliance with the principles of Good Laboratory practices.The test item in its original form was applied to the skin of Sprague-Dawley rats. The treated area was then covered by a semi-occlusive dressing for 24 hours. In first instance, the test item was administered sequentially at dose-levels of 200, 1000 then 2000 mg/kg to one female per dose-level, in order to evaluate the potential toxicity and local tolerance of the test item. According to the results obtained at each dose-level, a highest dose-level was tested or the dose-level was confirmed in four other females and tested in five males.
Mortality and clinical signs were checked daily for a period of 14 days following the single application of the test item. Body weight was recorded on days 1, 8 and 15. At the end of the 14-day observation period all animals were sacrificed and subjected to necropsy.
In the first step, at the dose-level of 200 and 1000 mg/kg, no mortality and systemic clinical signs were noted. The local reactions, as erythema (well-defined to severe), scabs, dryness and discoloration area (greenish, brownish or blackish) and/or oedema were observed with a similar severity.
According to these results, a highest dose-level of 2000 mg/kg was tested in one other female and then confirmed in four additionnal females and five males.No deaths and no relevant systemic clinical signs were observed during the study at the dose-level of 2000 mg/kg. Local reactions (erythema, dryness, edema, discoloration area and scabs) observed at 2000 mg/kg were similar in severity to those recorded at 1000 mg/kg. The body weight was not affected by the test item treatment. No abnormalities were observed at macroscopic examination.
Under these experimental conditions, the dermal LD0 of the substance was higher than or equal to 2000 mg/kg in rats.
Justification for classification or non-classification
According to the criteria laid down in EU regulation (EC) n° 1272/2008/EC (CLP) and EU directive67/548/EEC, the substance is not classified for acute oral and dermal toxicities.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)